SrideviRajeeveMD

Hematologic Oncology

Assistant Attending, Myeloma & Cell Therapy Service, Memorial Sloan-Kettering Cancer Center, NY

Dr. Rajeeve is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Physician-investigator with a clinical and research interest in plasma cell dyscrasias (Multiple Myeloma, Precursor states - MGUS/SMM, Amyloidosis, Waldenstrom's Macroglobulinemia, POEMS Syndrome etc.), cellular therapeutics, clinical trials, digital health technologies and healthcare delivery transformation.

Icahn School of Medicine at Mount SinaiFellowship, Hematology and Medical Oncology, 2020 - 2023
Icahn School of Medicine at Mount Sinai/Morningside/WestResidency, Internal Medicine, 2017 - 2020
Mahatma Gandhi UniversityClass of 2015, Bachelor of Medicine and Bachelor of Surgery (MBBS), Valedictorian

Domestic Scholar Award AIDS Malignancy Consortium
Young Investigator Award (YIA) American Society of Clinical Oncology (ASCO), 2022
HONORS Award and Grant American Society of Hematology (ASH)

PubMed

17 citations
Sequencing T-cell redirection therapies leads to deep and durable responses in patients with relapsed/refractory myeloma.
Tarek H Mouhieddine, Oliver Van Oekelen, David T Melnekoff, Jeanne Li, Yogita Ghodke-Puranik
Blood Advances. 2023-03-28
1 citations
Patterns of CRS with teclistamab in relapsed/refractory multiple myeloma with or without prior T-cell redirection therapy.
Issam S Hamadeh, Tala Shekarkhand, Colin Rueda, Ross S Firestone, Alice X Wang
Blood Advances. 2024-06-25
5 citations
Effect of additional cytogenetic abnormalities on survival in arsenic trioxide-treated acute promyelocytic leukemia.
Zachary D Epstein-Peterson, Andriy Derkach, Susan Geyer, Krzysztof Mrózek, Jessica Kohlschmidt
Blood Advances. 2022-06-14

Abstracts/Posters

Myelodysplastic Syndromes: Trends in Mortality, Costs of Hospitalizations, Length of Stay and Rate of Complications
Sridevi Rajeeve, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Pegaspargase Can Safely be Administered in Adults Age 40 and Older with Acute Lymphoblastic Leukemia
Sridevi Rajeeve, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Acute Myeloid Leukemia and Cirrhosis: Trends in Utilization of Induction Chemotherapy, Rate of Hospitalizations and Mortality
Sridevi Rajeeve, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Etiologies and Predictors of 30-Day Readmission in Patients Undergoing Induction Chemotherapy for Acute Myeloid Leukemia
Sridevi Rajeeve, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Risk Factors and Trends for Incidence of Acute Coronary Syndrome after Hematopoietic Stem Cell Transplant _ a 15-Year Experience with National Inpatient Sample
Sridevi Rajeeve, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Expectant Management of Extranodal Marginal Zone Lymphoma of Bronchial-Associated Lymphoid Tissue (BALT)
Sridevi Rajeeve, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Join now to see all